Related Experiment Video
Updated: Aug 10, 2026
12:43
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
Published on: February 21, 2011
Respiratory function in Parkinson's disease
Clinical Neuroscience (New York, N.Y.)
|April 29, 2000
Summary
Parkinson's disease (PD) causes respiratory problems like chest rigidity and airway issues, which can be improved with medication. However, some treatments may lead to lung damage and infections, increasing PD patient mortality.
Area of Science:
- Neurology
- Pulmonology
- Pharmacology
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder affecting motor function.
- Respiratory dysfunction is a common non-motor symptom in PD.
- Pulmonary complications significantly impact PD patient morbidity and mortality.
Purpose of the Study:
- To review the range of respiratory dysfunctions in Parkinson's disease (PD).
- To examine the effects of PD on ventilation and medication response.
- To outline pulmonary complications associated with antiparkinsonian therapies.
Main Methods:
- Literature review of respiratory dysfunction in Parkinson's disease.
- Analysis of primary pulmonary abnormalities in PD.
- Evaluation of medication-induced pulmonary complications.
Main Results:
- PD causes restrictive lung changes due to chest wall rigidity and upper airway obstruction, responsive to dopaminergic drugs.
- Levodopa therapy can induce respiratory dyskinesia, affecting ventilation.
- Ergot derivative treatments may lead to pleuropulmonary fibrosis.
- Pulmonary infections are a significant cause of mortality in PD patients due to impaired respiratory mechanics.
Conclusions:
- Respiratory dysfunction is multifaceted in PD, involving primary effects and treatment complications.
- Dopaminergic therapy can improve some PD-related respiratory issues.
- Antiparkinsonian drugs carry risks of pulmonary fibrosis and infection.
- Addressing respiratory complications is crucial for improving outcomes in Parkinson's disease.
Related Concept Videos
01:23Physiological Control of Respiration
Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...